PP
OXFD

Paloma Partners’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Paloma Partners’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-38,007
Closed -$632K – 2637
2019
Q3 		$632K Sell
38,007
-89,111
-70% -$1.23M 0.01% 992
2019
Q2 		$1.75M Buy
127,118
+116,709
+1,121% +$1.78M 0.03% 464
2019
Q1 		$179K Buy
+10,409
New +$165K ﹤0.01% 1543

Other funds holding OXFD

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Paloma Partners's OXFD Position: Q4 2019 in Review

Paloma Partners sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q4 2019, closing a stake of 38,007 shares — an estimated $632K sold.

Paloma Partners first reported a position in OXFD in Q1 2019 and held it in 3 quarters. The position peaked at $1.75M in Q2 2019. 68 funds tracked by Wall St. Rank hold OXFD as of Q4 2019.

  • Paloma Partners reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q4 2019 after selling out during the quarter.
  • Paloma Partners sold 38,007 Oxford Immunotec Global PLC Ordinary Shares shares in Q4 2019, an estimated $632K.
  • Paloma Partners first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q1 2019 and held it in 3 quarters.
  • Paloma Partners's Oxford Immunotec Global PLC Ordinary Shares position peaked at $1.75M in Q2 2019.
  • 68 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q4 2019.

Based on Paloma Partners's 13F filing for Q4 2019, filed 14 Feb 2020.